Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ulixertinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioMed Announces First Patient Dosed in PII Trial with Ulixertinib (BVD-523)
    BioMed Announces First Patient Dosed in PII Trial with Ulixertinib (BVD-523)

    12 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/biomed-valley-discoveries-announces-first-patient-dosed-in-phase-ii-combination-trial-with-ulixertinib-bvd-523-its-first-in-class-and-best-in-class-erk-inhibitor-in-combination-with-hydroxychloroquine-301621646.html

    PRNEWSWIRE
    12 Sep 2022
    Share Share